Depression

Live opening session from the American College of Cardiology meeting in Chicago 2016

sears tower Opening session at the American College of Cardiology meeting was fascinating.

Starting with Michelle Obama and her call to prevent childhood obesity. MO, noted that PREVENTION is a key to living longer, healthier lives. Couldn't agree more.

 

Shock at the Pharmacy Drive Up Window

Something is fishy  After lunch I stopped at a large Pharmacy chain to hand in 2 written prescriptions and to ask for a refill on one of the other prescriptions that my doctor had just called in. Three prescriptions, nothing unusual. (little did I know, something was fishy).

Flibanserin fine by FDA committee, with a risk plan recommendation

An FDA advisory panel voted 18 to 6 in favor of approval of the Sprout Pharmaceuticals medicine called flibanserin (Girosa). The FDA usually follows the recommendations of the expert panels, but is not bound to do so.

Flibanserin flies, but with safety restriction

An FDA advisory panel voted 18 to 6 in favor of approval of the Sprout Pharmaceuticals medicine called flibanserin (Girosa). The FDA usually follows the recommendations of the expert panels, but is not bound to do so.

Members Only: 

An FDA advisory panel voted 18 to 6 in favor of approval of the Sprout Pharmaceuticals medicine called flibanserin (Girosa). The FDA usually follows the recommendations of the expert panels, but is not bound to do so.

The recommendation for approval also came wirth some guidance. The committee suggested a plan to limit safety risks, something which is not unusual these days.


More to follow as this medicine moves toward aproval. I'll include this in the upcoming Essential Guide To Prescription Drugs and may complete a new eBook on it.

 

Flibanserin folly or real female benefit for decreased sexual desire?

bicycle on beach Flibanserin (Fluh BAN ser ihn) for female sexual desire has been a controversial medicine, possibly because of the way it works (increasing blood flow to the genitals), but more broadly, because of the condition (hypoactive sexual desire disorder- HSDD) that the medicine might tr

Female sexuality flies with flibanserin or is this a "made up" medicine?

bicycle on beach Flibanserin (Fluh BAN ser ihn) for female sexual desire has been a controversial medicine, possibly because of the way it works (increasing blood flow to the genitals), but more broadly, because of the condition (hypoactive sexual desire disorder- HSDD) that the medicine might treat.

Members Only: 

bicycle on beach Flibanserin (Fluh BAN ser ihn) for female sexual desire has been a controversial medicine, possibly because of the way it works (increasing blood flow to the genitals), but more broadly, because of the condition (hypoactive sexual desire disorder- HSDD) that the medicine might treat. Controversy surrounds HSDD and if it is a made up problem to sell medicines or if it is something that is a real problem which a significant number of women face.

Today, however is the day when the expert panel is meeting to take a very close and considered look. Is this a female Viagra? Should we care? History tells us that HSDD has been recognized as a problem for up to 7 % of women for about 40 years.

man and woman looking at beach The drug works on three chemicals known as neurotransmitters. Dopamine, serotonin and norepinephrine affect the brain's reward center and ability to feel pleasure in a way that researchers admitted to the meeting they don't fully understand. Side effects include sleepiness, fainting and fatigue, but these issues can be dealt with by taking the pill at bedtime.

It will be interesting to see how the panel votes today and if they recommend the medicine, if the FDA will follow the panel advice and approve it. I'll include data on this medicine in the upcoming Essential Guide to Prescription Drugs and may create a stand alone eBook if there is enough demand.

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.